靶點科技(北京)有限公司

氯膦酸鹽脂質(zhì)體清除肺臟巨噬細(xì)胞全肺流式檢測解決方案

時間:2024-9-9閱讀:379

Carbapenem-resistant Klebsiella pneumoniae (CRKP)感染小鼠模型,全肺臟流式檢測分群圈門策略,可以參考下圖。Gating strategy for determining the myeloid and lymphoid subsets in the whole lungs of control and Trpv1DTA mice after 48h of clodronate liposome (CLL) administration. PBS-liposome (PBL) was used for control group of mice. CLL or PBL (70 μL/mouse) was inoculated via intratracheal route at 48 hours before the immune cell type analyses. 單核巨噬清除訂購信息見后。


氯膦酸鹽脂質(zhì)體清除肺臟巨噬細(xì)胞全肺流式檢測解決方案

氯膦酸鹽脂質(zhì)體清除肺臟巨噬細(xì)胞全肺流式檢測解決方案

(A) Gating strategy for determining the myeloid and lymphoid subsets in the whole lungs of control and Trpv1DTA mice after 48h of clodronate liposome (CLL) administration. PBS-liposome (PBL) was used for control group of mice. CLL or PBL (70 μL/mouse) was inoculated via intratracheal route at 48 hours before the immune cell type analyses. Interstitial macrophages (IMs, CD45+Siglec-F–CD11b+Ly6G– F4/80+ cells), neutrophils (CD45+Siglec-F–CD11b+Ly6G+ cells), Ly6Chi monocytes (CD45+Siglec-F–CD11b+Ly6G– F4/80– Ly6Chi cells), Ly6Clo monocytes (CD45+Siglec-F–CD11b+Ly6G–F4/80–Ly6Clo cells), CD11b+ DC (CD45+Siglec-F–CD11b+Ly6G– F4/80–Ly6C– CD11c+ MHC-II+cells), CD11b– DCs (CD45+Siglec-F–CD11b– CD3– B220– NK1.1– CD11c+ MHC-II+cells), B cells (CD45+Siglec-F–CD11b– CD3–NK1.1–B220+cells), CD4+ T cells (CD45+Siglec-F–CD11b– CD3+ CD8–CD4+ cells), CD8+ T cells (CD45+Siglec-F–CD11b– CD3+ CD4–CD8+ cells) and CD4– CD8– T cells (CD45+Siglec-F–CD11b– CD3+ CD4–CD8– cells).

(B) Absolute numbers of myeloid and lymphoid subsets in the whole lungs of CLL- or PBL-treated control (n=3-4) and Trpv1DTA (n=3) mice after 48h of treatment.

(C) The BALF number of Ly6Chi monocytes, neutrophils, and AMs in CLL- and PBL-treated control (n=4) and Trpv1DTA mice (n=3-4) after 24h of CRKP infection. Statistical analysis: Mann Whitney test (B, left), unpaired ttests (B, right and C to E) with the following significance levels: (*P<0.05, **P<0.01,***P<0.001). ns, not significant.



品牌:Liposoma

產(chǎn)地:荷蘭

貨號:CP-005-005

規(guī)格:5ml+5ml

品名:Clodronateliposomes & Control Liposomes

代理:靶點科技

部位:肺臟

細(xì)胞:肺泡巨噬細(xì)胞(AM)

劑量:70ul

方式:滴鼻(intratracheal administration

時間點:建模前48h

題目Lung-innervating nociceptor sensory neurons promote pneumonic sepsis during carbapenem-resistant Klebsiella pneumoniae lung infection

期刊:SCIENCE ADVANCES

時間:6 Sep 2024

期卷:Vol 10, Issue 36

鏈接:DOI: 10.1126/sciadv.adl6162


Liposoma巨噬細(xì)胞清除劑氯膦酸二鈉脂質(zhì)體清除肺泡巨噬細(xì)胞AM:

氯膦酸鹽脂質(zhì)體清除肺臟巨噬細(xì)胞全肺流式檢測解決方案




會員登錄

X

請輸入賬號

請輸入密碼

=

請輸驗證碼

收藏該商鋪

X
該信息已收藏!
標(biāo)簽:
保存成功

(空格分隔,最多3個,單個標(biāo)簽最多10個字符)

常用:

提示

X
您的留言已提交成功!我們將在第一時間回復(fù)您~

以上信息由企業(yè)自行提供,信息內(nèi)容的真實性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),化工儀器網(wǎng)對此不承擔(dān)任何保證責(zé)任。

溫馨提示:為規(guī)避購買風(fēng)險,建議您在購買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。

撥打電話
在線留言